Morquio A Mucopolysaccharidoses, also known as MPS IV A, is a rare genetic disorder that affects the body's ability to break down and process certain types of sugary substances called glycosaminoglycans (GAGs). This disorder is caused by a deficiency in the enzyme N-acetylgalactosamine-6-sulfate sulfatase (GALNS) which leads to an abnormal accumulation of GAGs in various tissues and organs throughout the body.
There are two types of Morquio A, Type A and Type B. Type A is the more severe form of the disorder and is caused by a complete deficiency of the GALNS enzyme. Type B is a milder form of the disorder and is caused by a partial deficiency of the enzyme.
The symptoms of Morquio A can vary greatly from person to person, but they generally include:
Diagnosis of Morquio A usually involves a physical examination, medical history, and genetic testing. Doctors may also perform various imaging tests such as X-rays, CT scans, and MRI scans to evaluate bone abnormalities and organ enlargement.
While there is currently no cure for Morquio A, there are various treatments available to manage the symptoms of the disorder. Treatment options may include enzyme replacement therapy, surgery to correct bone abnormalities, and respiratory support such as continuous positive airway pressure (CPAP).
Morquio A Mucopolysaccharidoses is a rare genetic disorder that can have a significant impact on a person's quality of life. While there is no cure, early diagnosis and management of symptoms can help improve outcomes. If you or a loved one are experiencing any of the symptoms associated with Morquio A, it is important to speak with a healthcare professional for proper diagnosis and treatment.
To see full information about treatment please Sign up or Log in